ATE292282T1 - Verfahren zur zellseparation unter verwendung von immunorosetten - Google Patents

Verfahren zur zellseparation unter verwendung von immunorosetten

Info

Publication number
ATE292282T1
ATE292282T1 AT00930932T AT00930932T ATE292282T1 AT E292282 T1 ATE292282 T1 AT E292282T1 AT 00930932 T AT00930932 T AT 00930932T AT 00930932 T AT00930932 T AT 00930932T AT E292282 T1 ATE292282 T1 AT E292282T1
Authority
AT
Austria
Prior art keywords
cells
immunorosets
cell separation
immunorosettes
red blood
Prior art date
Application number
AT00930932T
Other languages
English (en)
Inventor
Terry E Thomas
Carrie Peters
Peter Lansdorp
Original Assignee
Stemcell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Technologies Inc filed Critical Stemcell Technologies Inc
Application granted granted Critical
Publication of ATE292282T1 publication Critical patent/ATE292282T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00930932T 1999-05-28 2000-05-26 Verfahren zur zellseparation unter verwendung von immunorosetten ATE292282T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13677099P 1999-05-28 1999-05-28
US19337100P 2000-03-31 2000-03-31
US20347700P 2000-05-11 2000-05-11
PCT/CA2000/000616 WO2000073794A2 (en) 1999-05-28 2000-05-26 Method for separating cells using immunorosettes

Publications (1)

Publication Number Publication Date
ATE292282T1 true ATE292282T1 (de) 2005-04-15

Family

ID=27384918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00930932T ATE292282T1 (de) 1999-05-28 2000-05-26 Verfahren zur zellseparation unter verwendung von immunorosetten

Country Status (11)

Country Link
US (2) US6448075B1 (de)
EP (1) EP1185867B1 (de)
JP (1) JP4526749B2 (de)
CN (1) CN1218182C (de)
AT (1) ATE292282T1 (de)
AU (1) AU769903B2 (de)
CA (1) CA2375115C (de)
DE (1) DE60019111T2 (de)
HK (1) HK1044819B (de)
IL (2) IL146660A0 (de)
WO (1) WO2000073794A2 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135335B2 (en) * 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
US20030157060A1 (en) * 2000-04-03 2003-08-21 Bell David N Production of tcr gamma delta t cells
US7205157B2 (en) * 2001-01-08 2007-04-17 Becton, Dickinson And Company Method of separating cells from a sample
US7160723B2 (en) * 2001-04-10 2007-01-09 Bioe, Inc. Cell separation compositions and methods
US6667022B2 (en) * 2001-08-14 2003-12-23 General Electric Co. Process for separating synthesis gas into fuel cell quality hydrogen and sequestration ready carbon dioxide
MXPA05003260A (es) * 2002-09-27 2005-09-12 Bioe Inc Composiciones y metodo de separacion de celulas.
EP1574583A1 (de) * 2004-03-10 2005-09-14 Roche Diagnostics GmbH Verfahren zur Isolierung von Bakterien aus biologischen Proben
EP1574584B1 (de) * 2004-03-10 2006-11-15 Boehringer Mannheim Gmbh Verfahren zur Isolierung von Bakterien aus biologischen Proben
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
ATE506431T1 (de) * 2004-04-23 2011-05-15 Bioe Llc Mehrfachlinien-vorläuferzellen
DE602006018595D1 (de) * 2005-04-08 2011-01-13 Medical Discovery Partners Llc Verfahren zum anreichern von subpopulationen seltener zellen aus dem blut
US20090208464A1 (en) * 2006-01-24 2009-08-20 Centeno Christopher J Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
EP2019858B1 (de) * 2006-04-17 2012-06-13 BioE LLC Differenzierung von vorläuferzellen mit mehreren abstammungslinien in respiratorischen epithelzellen
KR100833793B1 (ko) * 2006-05-16 2008-05-29 세원셀론텍(주) 골수 유래 골 생성용 유핵 세포 분리 방법
US7862813B2 (en) * 2006-07-29 2011-01-04 Bjork Jr Robert Lamar Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US9095562B2 (en) * 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
CN101835479A (zh) * 2007-07-25 2010-09-15 佰欧益有限公司 多系祖细胞分化为软骨细胞
US20110200642A1 (en) * 2007-12-19 2011-08-18 Regenerative Sciences, Llc Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
WO2009114785A2 (en) * 2008-03-14 2009-09-17 Regenerative Sciences, Inc. Compositions and methods for cartilage repair
WO2009143241A2 (en) * 2008-05-21 2009-11-26 Bioe, Inc. Differentiation of multi-lineage progenitor cells to pancreatic cells
CN102325536A (zh) 2008-12-05 2012-01-18 再生科学有限责任公司 促进无血管组织修复的方法和组合物
US20100168022A1 (en) * 2008-12-11 2010-07-01 Centeno Christopher J Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
WO2010125932A1 (ja) * 2009-04-28 2010-11-04 コニカミノルタホールディングス株式会社 融合タンパク質含有集合体、その製造方法及び該集合体を用いたアッセイ法
US20110054929A1 (en) * 2009-09-01 2011-03-03 Cell Solutions Colorado Llc Stem Cell Marketplace
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
JP5846609B2 (ja) 2010-01-21 2016-01-20 バイオセップ リミテッド 希少細胞の磁気分離
FR2963108B1 (fr) * 2010-07-21 2017-06-23 Diagast Procede magnetique d'immunodiagnostic et kit pour la mise en evidence de complexe anticorps/antigene de groupe/phenotype sanguin
WO2012018930A1 (en) * 2010-08-03 2012-02-09 University Of Miami Methods of isolating and expanding human t regulatory cells and uses thereof for cellular therapy
AU2011343735A1 (en) 2010-12-15 2013-07-18 Cytosed, Inc. Antibody-linked immuno-sedimentation agent and method of isolating a target from a sample using same
PL2726603T3 (pl) 2011-06-29 2020-10-05 Biorestorative Therapies, Inc. Kompozycje i sposoby dotyczące brązowych komórek tłuszczowych
EP2597153B1 (de) 2011-11-25 2016-10-05 Miltenyi Biotec GmbH Zelltrennverfahren
DE102012003700B3 (de) * 2012-02-28 2012-11-29 FLACOD GmbH Verfahren zur Trennung von Verbänden maligner Zellen und Verbänden aus Stromazellen einer Malignomgewebeprobe
US8921055B2 (en) 2012-10-30 2014-12-30 Berkeley Lights, Inc. Detecting cells secreting a protein of interest
WO2014138887A1 (en) 2013-03-15 2014-09-18 Stemcell Technologies Inc. Method for separating cells using immunorosettes and magnetic particles
JP6179999B2 (ja) 2013-09-30 2017-08-16 積水メディカル株式会社 循環腫瘍細胞濃縮分離デバイス及び循環腫瘍細胞の濃縮分離方法
BR112016016740B1 (pt) 2014-01-21 2024-02-20 Stemcell Technologies Inc Método de separação de entidades alvo de uma amostra que compreende entidades alvo e entidades não alvo
CA2996848C (en) * 2014-09-04 2021-01-05 Stemcell Technologies Inc. Soluble antibody complexes for t cell or nk cell activation and expansion
GB201418382D0 (en) * 2014-10-16 2014-12-03 Ge Healthcare Uk Ltd Device and method for separating cells
EP3037170A1 (de) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Multisort-Zelltrennverfahren
WO2016122014A1 (ko) * 2015-01-27 2016-08-04 한국생명공학연구원 자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도
EP3307785A4 (de) 2015-06-10 2018-12-05 Stemcell Technologies Inc. Verfahren zur in situ-herstellung von bifunktionellen immunologischen komplexen
JP6779483B2 (ja) 2016-09-29 2020-11-04 住友ゴム工業株式会社 医療用検査装置及び細胞検査方法
EP3595683A1 (de) * 2017-03-15 2020-01-22 Orca Biosystems, Inc. Zusammensetzungen und verfahren für hämatopoietische stammzelltransplantate
JP7109719B2 (ja) 2018-02-14 2022-08-01 住友ゴム工業株式会社 特定細胞捕捉方法
WO2019232631A1 (en) * 2018-06-06 2019-12-12 Stemcell Technologies Canada Inc. Kits, compositions and methods for myeloid-derived suppressor cell enrichment
US11614440B2 (en) 2019-01-24 2023-03-28 Sumitomo Rubber Industries, Ltd. Specific cell fractionating and capturing methods
US11725042B2 (en) 2019-06-27 2023-08-15 Stemcell Technologies Canada Inc. Methods and devices for complexing target entities

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
LU86752A1 (fr) * 1987-01-30 1988-08-23 Univ Bruxelles Procede de production d'anticorps monoclonaux humains(igg)anticytomegalovirus et anticorps monoclonaux ainsi obtenus
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
AU8869291A (en) * 1990-10-04 1992-04-28 University Of Virginia Alumni Patents Foundation, The Primate erythrocyte bound monoclonal antibody heteropolymers
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
WO1994027698A2 (en) * 1993-05-28 1994-12-08 Baxter International Inc. Continuous centrifugation process for the separation of biologic components from heterogeneous cell populations
US6117985A (en) 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
US6306575B1 (en) 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
DE19710496A1 (de) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen
US6572856B1 (en) * 1998-09-10 2003-06-03 The University Of Virginia Patent Foundation Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies

Also Published As

Publication number Publication date
CN1367876A (zh) 2002-09-04
IL146660A0 (en) 2002-07-25
AU4905900A (en) 2000-12-18
DE60019111T2 (de) 2006-01-26
WO2000073794A3 (en) 2001-08-30
IL146660A (en) 2007-10-31
CA2375115A1 (en) 2000-12-07
CA2375115C (en) 2011-05-24
AU769903B2 (en) 2004-02-05
WO2000073794A2 (en) 2000-12-07
HK1044819A1 (en) 2002-11-01
US6448075B1 (en) 2002-09-10
EP1185867A2 (de) 2002-03-13
US20030092078A1 (en) 2003-05-15
DE60019111D1 (de) 2005-05-04
JP4526749B2 (ja) 2010-08-18
US6872567B2 (en) 2005-03-29
HK1044819B (zh) 2005-07-29
EP1185867B1 (de) 2005-03-30
CN1218182C (zh) 2005-09-07
JP2003501629A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE187501T1 (de) Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
GB2374415B (en) Human antibodies as detection reagents
DE3851967D1 (de) Verfahren zur Bestimmung von Antikörpern.
ATE459652T1 (de) Verfahren zur herstellung von antikörpern
DE69626418T2 (de) Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation
ATE85131T1 (de) Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch.
DE3486350D1 (de) VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
DE602005000249D1 (de) Verfahren zur Isolierung von Bakterien aus biologischen Proben
FI925781A (fi) Analys av analytvarianter
DE69323589D1 (de) Einen Basophilen bindender monoclonaler Antikörper, Verfahren zur Abtrennung von Basophilen, Verfahren für die Freisetzung von chemischen Vermittlern aus Basophilen, und Verfahren zur Prüfung der Freisetzung von von Basophilen abgeleiteten chemischen Vermittlern
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
GB2326943B (en) Detection of fetal red cells in maternal blood
DE69633740D1 (de) Verfahren zur auswahl einer population oder subpopulation einer probe unter verwendung von partikel-und schwerkraft -sedimentation
ATE185900T1 (de) Festphasen-filtrationsverfahren zur antigen- und antikörperprüfung in der blutgruppen-serologie, und testsatz
DK426588D0 (da) Fremgangsmaade til paavisning af celleoverfladeantigen
DE69737329D1 (de) Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
ATE534907T1 (de) Verfahren für den nachweis von l523s-expression in biologischen proben
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
JP2009014572A (ja) ヒト赤血球が固相化されたクロスマッチ試験用容器の製造方法
FI974043A (fi) Menetelmä mikrobiologisten näytteiden viljelemiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties